<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03663517</url>
  </required_header>
  <id_info>
    <org_study_id>CUHK_TMP00159</org_study_id>
    <nct_id>NCT03663517</nct_id>
  </id_info>
  <brief_title>Gestational Age Specific Thyroid Function Reference Range</brief_title>
  <official_title>Gestational Age Specific Thyroid Function Reference Range in Hong Kong</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has been well accepted that maternal thyroid dysfunction has adverse affects on both
      mothers and fetuses. However, the dramatical changes during pregnancy make the interpretation
      of thyroid function test (TFT, i.e. free triiodothyronine [FT3], free thyroxine [FT4] and
      thyrotropin [TSH]) very difficult. Previous studies have shown that the level of thyroid
      hormones differs from non-pregnant population and varies from gestational ages. Moreover,
      studies have shown the agreement among different instrument platforms was quite low. This
      study is aimed to determine gestational age specific TFT reference ranges of the local
      pregnant population for all available platforms currently used under Hospital Authority and
      Department of Health.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2, 2014</start_date>
  <completion_date type="Actual">April 30, 2016</completion_date>
  <primary_completion_date type="Actual">April 30, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of free triiodothyronine (FT3) during pregnancy</measure>
    <time_frame>At the time of booking for antenatal visit (1st trimester), oral glucose tolerance test (24-32 weeks), admission for delivery (3rd trimester) and a gestational age assigned randomly.</time_frame>
    <description>gestational FT3 level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of free thyroxine (FT4) during pregnancy</measure>
    <time_frame>At the time of booking for antenatal visit (1st trimester), oral glucose tolerance test (24-32 weeks), admission for delivery (3rd trimester) and a gestational age assigned randomly.</time_frame>
    <description>gestational FT4 level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of thyrotropin (TSH) during pregnancy</measure>
    <time_frame>At the time of booking for antenatal visit (1st trimester), oral glucose tolerance test (24-32 weeks), admission for delivery (3rd trimester) and a gestational age assigned randomly.</time_frame>
    <description>gestational TSH level</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">599</enrollment>
  <condition>Thyroid</condition>
  <condition>Reference Values</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>pregnant women</arm_group_label>
    <description>pregnant women in Hong Kong</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Cord blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Hong Kong women
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women receiving pregnancy and postnatal care in the Department of Obstetrics
             &amp; Gynaecology, Prince of Wales Hospital, Hong Kong

        Exclusion Criteria:

          -  1. Previous history of thyroid dysfunction (hypothyroidism or hyperthyroidism);

          -  2. Autoimmune disease, particularly those receiving corticosteroid or
             immunosuppressant: e.g. systemic lupus erythematosus;

          -  3. Disease associated with thyroid dysfunction: e.g. molar pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Gestational age-specific thyroid function reference range</gender_description>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wing Hung Tam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese University of Hong Kong</affiliation>
  </overall_official>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>August 21, 2018</study_first_submitted>
  <study_first_submitted_qc>September 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 10, 2018</study_first_posted>
  <last_update_submitted>September 6, 2018</last_update_submitted>
  <last_update_submitted_qc>September 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Wing Hung Tam</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Thyroid</keyword>
  <keyword>Reference values</keyword>
  <keyword>Pregnancy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>To be confirmed.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

